An independent analysis found virtual mental health solutions for depression and anxiety effectively treat the conditions, ...

An estimated 21 million adults in the U.S. live with depression, and over half experience treatment-resistant depression.

This groundbreaking research, published in Molecular Psychiatry, found that an anti-inflammatory drug called infliximab may ...

For the nearly 30 percent of major depressive disorder patients who are resistant to treatment, ketamine provides some amount of normalcy, but it requires frequent treatment and can have side effects.

A mechanism involving potassium channels in the brain that control brain cell activity could provide a new and fundamentally different way of treating depression symptoms in adults with major ...

A mechanism involving potassium channels in the brain that control brain cell activity could provide a new and fundamentally ...